HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Antiplatelets vs anticoagulation for dissection: CADISS nonrandomized arm and meta-analysis.

AbstractOBJECTIVE:
To present the results of the nonrandomized arm of the Cervical Artery Dissection in Stroke Study (CADISS-NR) trial, comparing anticoagulation and antiplatelets for prevention of recurrent stroke after carotid and vertebral dissection, and perform a meta-analysis of these results with previously published studies comparing the 2 therapeutic strategies.
METHODS:
A total of 88 patients from 22 centers with extracranial carotid and vertebral dissection were recruited within 1 month of symptom onset. The primary endpoint was recurrent stroke at 3 months. A systematic review was performed, and results of published studies included in a meta-analysis with the CADISS-NR results.
RESULTS:
In CADISS-NR, one patient in each group had recurrent ischemic stroke (antiplatelet 1/59 [1.69% ], anticoagulation 1/28 [3.57%]). At the primary endpoint of 3 months, 3 (5.08%) antiplatelet patients had recurrent TIA, compared with none in the anticoagulation group. For meta-analysis, there were data from 40 nonrandomized studies including 1,636 patients. There was no significant difference between the 2 treatments in recurrent stroke risk (antiplatelet 13/499 [2.6%], anticoagulant 20/1,137 [1.8%], odds ratio [OR] 1.49) or risk of death (antiplatelet 5/499 [1.00%], anticoagulant 9/1,137 [0.80%], OR 1.27).
CONCLUSION:
There is no evidence for superiority of anticoagulation or antiplatelet therapy in prevention of stoke after carotid and vertebral artery dissection; however, all data are from nonrandomized studies and randomized studies are required. The nonrandomized CADISS data show a lower rate of recurrent stroke than reported in some previous studies.
CLINICAL TRIAL REGISTRATION INFORMATION:
www.dissection.co.uk, ISRNCTN44555237.
AuthorsFiona Kennedy, Silvia Lanfranconi, Cara Hicks, John Reid, Patrick Gompertz, Christopher Price, Sally Kerry, John Norris, Hugh S Markus, CADISS Investigators
JournalNeurology (Neurology) Vol. 79 Issue 7 Pg. 686-9 (Aug 14 2012) ISSN: 1526-632X [Electronic] United States
PMID22855862 (Publication Type: Comparative Study, Controlled Clinical Trial, Journal Article, Meta-Analysis, Research Support, Non-U.S. Gov't, Systematic Review)
Chemical References
  • Anticoagulants
  • Platelet Aggregation Inhibitors
Topics
  • Adult
  • Anticoagulants (therapeutic use)
  • Carotid Artery, Internal, Dissection (drug therapy)
  • Female
  • Humans
  • Male
  • Platelet Aggregation Inhibitors (therapeutic use)
  • Stroke (drug therapy, prevention & control)
  • Treatment Outcome
  • Vertebral Artery Dissection (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: